Hepatitis C-A clinical review-Reference-Cited by-同舟云学术

Hepatitis C-A clinical review

Published:2016-04-29 Issue:11 Volume:88 Page:1844-1855
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Wang Lan S.¹,D'Souza Lionel S.²,Jacobson Ira M.²

Affiliation:

1. Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine; University of Texas Health Science Center at Houston; Houston Texas

2. Division of Digestive Diseases, Department of Medicine; Mount Sinai Beth Israel Medical Center, New York; New York

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmv.24554/fullpdf

Reference116 articles.

1. http://www.hcvguidelines.org 2015

2. Clinicaltrials.gov

3. Abergel A Loustaud-Ratti V Meltivier S Jiang D Kersey K Knox SJ Pang PS Samuel D Asselah T 2015

4. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection;Afdhal;N Engl J Med,2014a

5. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection;Afdhal;N Engl J Med,2014b

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of ABO Blood Groups System with Infection to Hepatitis C Virus: A Tertiary Hospital Study in India;2023-12-14

2. Development of an in vitro model to study hepatitis C virus-induced fibrosis;Future Virology;2023-08

3. Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C;Russian Journal of Gastroenterology, Hepatology, Coloproctology;2023-06-04

4. Syringe Services Programs to Reduce Intravenous Disease Transmission in Substance Use Disorders;Nursing Clinics of North America;2023-06

5. Fingerprint-based QSAR Model Generation to Identify Structural Determinants of HCV NS5B Inhibition;Journal of Research in Pharmacy;2023